Delivery Order SPE2DB22D3010-SPE2DB26FP0TN
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $41,754.56 to AmerisourceBergen Drug Corp for RINVOQ ER 15 MG tablets (30-count units) on September 15, 2025, with a completion date of September 16, 2025. This firm fixed-price, competitively awarded delivery order was issued under a non-set-aside procurement and represents a single line-item pharmaceutical supply to support federal medical needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a...
- The Defense Logistics Agency awarded a delivery order valued at $10,040.64 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) with a firm fixed price structure. This non-set-aside competitive award was issued on September 26, 2025, with an ultimate completion date of September 29, 2025. The contract is to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company operates as a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a delivery order valued at $4,265.94 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on August 26, 2025, with completion targeted for August 27, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under an existing contract vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $45,395.82 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-unit package) on September 24, 2025, with completion scheduled for September 25, 2025. This non-set-aside, competitively awarded contract reflects firm fixed pricing for pharmaceutical delivery to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $41,153.31 to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count units). This firm fixed-price, competitively awarded delivery order is scheduled for completion by September 4, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a non-set-aside award, indicating the opportunity was open to all...
- The Defense Logistics Agency awarded a delivery order valued at $10,772.76 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-unit package) on July 25, 2025, with completion expected by July 28, 2025. This competitively awarded, firm fixed-price delivery order represents a procurement of pharmaceutical inventory supporting military healthcare operations. The contract carries no set-aside designation and is being performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $6,147.19 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on August 8, 2025, with completion scheduled for August 11, 2025. This firm fixed-price, non-set-aside contract represents a routine pharmaceutical supply delivery to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $40,986.91 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on August 19, 2025, with an ultimate completion date of August 20, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $4,684.70 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on June 4, 2025, with completion scheduled for June 5, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating open competitive award. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and this delivery...
- The Defense Logistics Agency awarded a delivery order valued at $9,702.86 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on September 12, 2025, with completion targeted for September 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- SPE2DB22D3010Indefinite Delivery Contract
- SPE2DB22D3010-SPE2DB26FP0TNDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,186.03 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30 count) on October 27, 2025, with completion expected by October 28, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents pharmaceutical procurement to support federal medical supply needs. The vendor, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical supplier for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp's federal contract portfolio demonstrates its capability to fulfill diverse medical procurement requirements across multiple therapeutic domains, including specialty medications, vaccines, and medical supplies, while serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.2k | 10/27/25 |